This study aimed to analyze the risk factors for piperacillin-tazobactam (TZP 1)-resistant
Enterobacter spp. bacteremia. The medical records of 111 patients with Enterobacter spp …

Resistance to a variety of frequently used antimicrobials in hospital-associated pathogen is
one of the biggest challenge which have significant impact on patient's outcome and health …

Both patients have been empirically treated with piperacillin-tazobactam and remain
critically ill. The microbiology laboratory updates the culture results as Enterobacter cloacae …

POKUD je in vitro citlivý k cefotaximu, ceftriaxonu nebo ceftazidimu, PAK BUĎ se přidá
poznámka, že monoterapie cefotaximem, ceftriaxonem nebo ceftazidimem, stejně jako léčba …

The incidence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales
(ESBL-EB) and carbapenem-resistant Enterobacterales (CRE) infections has been …

Gram negative infections are responsible for causing infections in both community and
healthcare settings. The proportion of infections caused by resistant gram negative …

Why the newly licensed antibiotic cefepime should be introduced to UK formularies - The
Pharmaceutical Journal Skip to content The Royal Pharmaceutical Society's official journal PJ …

In an era of increasing antimicrobial resis­ tance, clinicians are hard-pressed to use
narrow-spectrum agents to preserve antibi­ otic activity. Mortality rates for patients with …

Infectious complications following prostate biopsy are reported to be increasing in incidence
with associated individual and public health burden. Complication rates parallel a rise in …

Antimicrobial resistance may be intrinsic or acquired and is associated with poor clinical
outcomes and breakthrough infections during treatment and prophylaxis. Given their …